Can retatrutide cause a skin rash?

This site's retatrutide citations do not report skin rash as a measured outcome. What they do report on skin-related sensation is dysesthesia, an unusual tingling or numb feeling, in about 12.5% of participants on the 12 milligram dose in TRIUMPH-1 (2,339 people, up to 28.3% mean weight loss at 80 weeks). That is a sensory finding, not a rash count. Gastrointestinal effects are the class pattern. This FAQ does not invent a rash rate from that sensory finding.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of names, absences, and legal limits. Brand versus molecule, side effects this site's citations did not measure, how long the trials actually ran, what national legal-status fields can say, and why two-compound answers do not scale to a larger stack.